Valuation: Repligen Corporation

Market Cap 10.22B 8.76B 8.19B 7.5B 14.08B 978B 14.26B 96.8B 37.75B 491B 38.38B 37.55B 1,625B P/E 2026 *
240x
P/E 2027 * 105x
Enterprise Value 9.99B 8.56B 8.01B 7.33B 13.75B 956B 13.93B 94.59B 36.89B 480B 37.51B 36.69B 1,588B EV / Sales 2026 *
12.1x
EV / Sales 2027 * 10.1x
Free-Float
94.32%
Yield 2026 *
-
Yield 2027 * -
1 day+0.47%
1 week+8.57%
Current month+28.45%
1 month+29.30%
3 months+57.42%
6 months+33.50%
Current year+10.54%
1 week 164.62
Extreme 164.62
188.73
1 month 130.03
Extreme 130.03
188.73
Current year 100.99
Extreme 100.99
188.73
1 year 100.99
Extreme 100.99
188.73
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap.
7/16/26 Sell

Chief Financial Officer

-530 0.0009%
6/25/26 Sell

Chief Financial Officer

-733 0.0013%
5/14/26 Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+0.47%+8.57%+45.15%+11.94% 10.22B
+2.19%+4.84%-12.03%+10.93% 202B
+1.14%+2.28%+0.69%+11.50% 119B
+1.06%+1.34%+8.69%+78.71% 60.69B
-1.37%-6.57%+30.31%+55.01% 52.38B
+2.33%+4.69%-3.84%-30.36% 52.3B
+2.35%+2.89%+12.25%-13.68% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+42.46%-10.20% 24.85B
-0.29%-3.87%-6.19%+25.59% 23.84B
Average +1.28%+1.11%+13.05%+15.49% 61.05B
Weighted average by Cap. +1.51%+2.01%+2.35%+16.63%

Financials

2026 *2027 *
Net sales 827M 708M 663M 607M 1.14B 79.13B 1.15B 7.83B 3.05B 39.75B 3.11B 3.04B 131B 969M 830M 777M 711M 1.33B 92.74B 1.35B 9.18B 3.58B 46.59B 3.64B 3.56B 154B
Net income 41.92M 35.91M 33.6M 30.76M 57.72M 4.01B 58.49M 397M 155M 2.01B 157M 154M 6.66B 98.84M 84.67M 79.22M 72.52M 136M 9.46B 138M 936M 365M 4.75B 371M 363M 15.71B
Net Debt -234M -200M -187M -171M -322M -22.36B -326M -2.21B -863M -11.23B -877M -858M -37.15B -407M -349M -326M -299M -561M -38.97B -568M -3.86B -1.5B -19.58B -1.53B -1.5B -64.75B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-08-21 $181.13 +0.47% 1,097,219
26-08-20 $180.29 +2.23% 1,591,724
26-08-19 $176.36 +6.15% 1,898,690
26-08-18 $166.15 -1.71% 462,720
26-08-17 $169.04 +1.32% 658,901
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
181.13USD
Average target price
185.70USD
Spread / Average Target
+2.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock